Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Alterations of Gut Derived Uremic Toxins and Microbiome Metabolites by Multispecies Synbiotic Supplementation in Hemodialysis Patients

NCT07443280 is registered in ClinicalTrials.gov with Tungs' Taichung Metroharbour Hospital as lead sponsor.

NCT NCT07443280
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07443280 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Alterations of Gut Derived Uremic Toxins and Microbiome Metabolites by Multispecies Synbiotic Supplementation in Hemodialysis Patients
Lead sponsor
Tungs' Taichung Metroharbour Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
May 4, 2026
Completion date
December 31, 2026
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gut -microbiota, symbiotic, uremic toxins